Ergoteles’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-136,320	Closed	-$529K	–	1362
2021 Q3	$529K	Sell	136,320 -2,861	-2%	-$11.1K	0.02%	557
2021 Q2	$445K	Buy	+139,181	New	+$445K	0.01%	868